Home
About
Overview
Sharing Data
ORCID
Help
History (9)
TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study.
Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer.
Expression and mutational analysis of MET in human solid cancers.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Expression and mutational analysis of MET in human solid cancers.
Expression and mutational analysis of MET in human solid cancers. Genes Chromosomes Cancer. 2008 Dec; 47(12):1025-37.
View in:
PubMed
subject areas
Gene Expression
Humans
Lung Neoplasms
Mutation
Neoplasms
Neovascularization, Pathologic
Oligonucleotide Array Sequence Analysis
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-met
Receptors, Growth Factor
Stem Cells
Tumor Cells, Cultured
authors with profiles
Ramasamy Jagadeeswaran
Thomas Krausz
Ravi Salgia
Everett Vokes